The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

A new research paper reframes the simulation hypothesis, asking whether reality could be simulated and what science can test.

Science can now explain the connection between information and consciousness. The answer is simpler—and stranger—than you might expect. The key is self-reference.

In this Monday edition of quantum computing news, we look at a new push by SEALSQ ($LAES) to build silicon-based quantum systems, Xanadu’s early ...

Abstract: The recursive T-matrix algorithms are used to solve for the vector electromagnet scattering problem of a three-dimensional array of patches. The formulation uses only the E/sub x/ and E/sub ...

Abstract: We extend the state-of-the-art online dereverberation method, online weighted prediction error (WPE), which predicts late reverberation components using a ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...